Kane Biotech Inc (KNE.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 163 | 218 | 239 | 263 | 188 |
| Accounts receivable | 52 | 15 | 6 | -15 | 44 |
| Other Working Capital | -877 | -5,835 | 590 | -378 | 1,293 |
| Other Operating Activity | -2,592 | 1,490 | -2,917 | -2,914 | -3,814 |
| Operating Cash Flow | $-3,255 | $-4,111 | $-2,082 | $-3,043 | $-2,289 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 55 | -25 | -9 | -13 | -187 |
| Net Acquisitions | 0 | 10,852 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -108 | -65 | -41 | -75 | -167 |
| Other Investing Activity | 0 | -494 | -66 | -20 | -20 |
| Investing Cash Flow | $-53 | $10,268 | $-116 | $-108 | $-374 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 972 | 0 | 2,010 | 2,777 | 1,796 |
| Debt Repayment | -307 | -6,655 | -482 | -527 | -536 |
| Common Stock Issued | 3,227 | 0 | 416 | 974 | N/A |
| Other Financing Activity | -41 | -1,032 | 1,039 | -121 | 1,548 |
| Financing Cash Flow | $3,851 | $-7,686 | $2,982 | $3,103 | $2,808 |
| Beginning Cash Position | 0 | 1,139 | 1,105 | 1,153 | 1,008 |
| End Cash Position | 902 | 359 | 749 | 1,105 | 1,153 |
| Net Cash Flow | $543 | $-2,669 | $784 | $-48 | $145 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,255 | -4,111 | -2,082 | -3,043 | -2,289 |
| Capital Expenditure | -113 | -90 | -50 | -88 | -354 |
| Free Cash Flow | -3,369 | -4,201 | -2,132 | -3,131 | -2,643 |